Table 2. Major Secondary Endpoints of Induction Studies in the Overall Population and Japanese Subpopulation.

Endpoints	UNITI-1						UNITI-2
	Placebo		130 mg		~6 mg/kg		Placebo		130 mg		~6 mg/kg
	Japan	All	Japan	All	Japan	All	Japan	All	Japan	All	Japan	All
Number	18	247	19	245	19	249	9	209	8	209	9	209
Clinical response at wk 8	27.8	20.2	21.1	33.5a	52.6	37.8b	0	32.1	37.5	47.4b	66.7	57.9b
Clinical remission at wk 8	5.6	7.3	10.3	15.9a	26.3	20.9b	0	19.6	25.0	30.6a	22.2	40.2b
70-Point response at wk 3	27.8	27.1	42.1	38.4a	42.1	40.6a	11.1	31.6	25.0	49.3b	44.4	50.7b
70-Point response at wk 6	44.4	30.4	42.1	46.1b	52.6	43.8a	11.1	38.8	50.0	58.9b	77.8	64.6b

Values are presented as percentage.

^aP<0.01 vs. placebo.

^bP<0.001 vs. placebo.